Éric Lefebvre

Éric Lefebvre, M.D. has been a member of the Board since March 2022. Dr. Lefebvre has served as Chief Medical Officer of Pliant Therapeutics, Inc., since May 2018. Prior to joining Pliant, Dr. Lefebvre served as the Vice President of Research and Development of Allergan plc, from November 2016 until April 2018. Prior to Allergan, Dr. Lefebvre served as Chief Medical Officer of Tobira Therapeutics, Inc, from January 2012 until November 2016. Dr. Lefebvre also led global clinical development and global medical affairs at Janssen Pharmaceuticals for 10 years prior to starting his pharmaceutical career at GlaxoSmithKline Canada. This was preceded by 15 years of providing primary care at Clinique Medicale L’Actuel in Montreal, Canada. He holds a B.S. in Health Sciences from Edouard-Montpetit College and an M.D. from the University of Montreal.